(84 days)
Not Found
No
The description focuses on a rule-based 3D analysis of image structure and averaging techniques for noise reduction, without mentioning AI, ML, or related concepts like training or inference.
No.
The device is a software tool for enhancing medical image presentation (noise reduction and contrast enhancement) and does not directly treat or diagnose a disease or condition.
No
The device is intended to enhance image presentation for radiologists and specialists by reducing noise and enhancing contrast in CT and 3D-XA images. This is a post-processing tool that aids in the viewing of images for diagnosis, rather than performing the diagnosis itself. The software preserves structural details for visual assessment, indicating its role is to improve the quality of images for human interpretation, not to provide a direct diagnostic output.
Yes
The device description explicitly states it is "software" and a "tool available on the Vitrea platform," focusing solely on image processing and enhancement techniques without mentioning any associated hardware components that are part of the device itself.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- Device Function: The Vitrea Image Denoising software is a post-processing tool that enhances existing medical images (CT and 3D-XA) acquired from imaging systems. It manipulates the visual presentation of these images to assist radiologists and specialists in their interpretation.
- No Specimen Handling: The device does not interact with or analyze biological specimens from the human body. Its input is image data, not biological samples.
Therefore, the Vitrea Image Denoising software falls under the category of medical image processing software, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
Vitrea® Image Denoising software is intended to assist radiologists and specialists in the enhancement of CT and 3D-XA image presentation by enabling noise reduction and contrast enhancement technique.
Product codes (comma separated list FDA assigned to the subject device)
LLZ
Device Description
The Vitrea Image Denoising software is a tool available on the Vitrea platform. It assists radiologists and specialists in the enhancement and viewing of CT and 3D-XA images from a variety of diagnosis imaging systems by noise reduction and contrast enhancement. Vitrea Image Denoising software employs 3D analysis of the image structure of each voxel. Random noise does not have a 3D structure and can thus be separated from dominant structures. Once the structure has been determined, the denoising tool suppresses noise by averaging voxel information without removing important structural details for reducing the noise.
It provides a control to turn on or off a denoising preset in Multi-planar Reformatting (MPR) and 3D views to reduce noise and enhance contrast in reconstructed CT and 3D-XA image datasets, while preserving structural details of contrast, spatial size, and 3D structure in the native images for visual assessment. The user can interactively apply and remove the noise reduction filter during the image review to assess the effect of the noise reduction on the images and generate a new series of denoised snapshots for further review in other workstations or PACS. The denoised images can be used in conjunction with the original images as the user can switch between the original image and the denoised image while conducting image review. It also enables the user to create new denoising presets, edit existing denoising presets, and save the current denoising values as a custom preset.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
CT and 3D-XA
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Radiologists and specialists. / Medical facility.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The software was designed, developed and tested according to written procedures that included applying risk management. Software testing was completed to ensure the new feature operates according to its requirements and without impact to existing functionality. Testing included verification, validation, and evaluation of previously acquired medical images.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
K140395
Page 1 of 7
Vitrea® Image Denc 510(k) Pre-market Notification
VITAL
A Tepton Microsystems Group Company
510(k) Summarv
This 510(k) summary is submitted in accordance with the requirements of 21 C.F.R. Part 807.92.(c)
| Purpose of
Submission: | Vital Images, Inc. hereby submits this traditional 510(k) to provide
notification submission of Vitrea Image Denoising software as an addition
to the existing tools on the 510(k) cleared Vitrea platform. |
|--------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Submitter: | Vital Images, Inc.
5850 Opus Parkway
Suite 300
Minnetonka, MN 55343-4414 |
| Establishment
Registration: | 2134213 |
| Contact Person: | Parthiv Shah
Sr. Regulatory Affairs Specialist
Phone : 952-487-9574
Fax: 952-487-9510
E-mail: pshah@vitalimages.com |
| 510(k) Type: | Traditional |
| Summary Date: | February 14, 2014 |
| Device Name
Trade Name: | Vitrea® Image Denoising Software |
| Common Name: | Image Enhancement System |
| Classification Name: | System, Image Processing, Radiological (21 C.F.R. 892.2050, LLZ) |
| Regulatory Description: | Picture Archiving and Communications System |
Predicate Device: Sapheneia Commercial Products AB, Sapheneia Clarity™ (K063391)
Device Description:
The Vitrea Image Denoising software is a tool available on the Vitrea platform. It assists radiologists and specialists in the enhancement and viewing of CT and 3D-XA images from a variety of diagnosis imaging systems by noise reduction and contrast enhancement. Vitrea Image Denoising software employs 3D analysis of the image structure of each voxel. Random noise does not have a 3D structure and can thus be separated from dominant structures. Once the structure has been determined, the denoising tool suppresses noise by averaging voxel information without removing important structural details for reducing the noise.
It provides a control to turn on or off a denoising preset in Multi-planar Reformatting (MPR) and 3D views to reduce noise and enhance contrast in reconstructed CT and 3D-XA image datasets, while preserving structural details of contrast, spatial size, and 3D structure in the native images for visual assessment. The user can interactively apply and remove the noise reduction filter during the image review to assess the effect of the noise reduction on the images and generate a new series of denoised snapshots for further review in other workstations or PACS. The denoised images can be used in conjunction with the original images as the user can switch between the original image and the denoised image while conducting image review. It also enables the user to create new denoising presets, edit existing denoising presets, and save the current denoising values as a custom preset.
1
Vitrea® Image Denoising Software 510(k) Pre-market Notification
A Toshiba Medical Systems Group Company
Intended Use / Indications for Use:
Vitrea® Image Denoising software is intended to assist radiologists and specialists in the enhancement of CT and 3D-XA image presentation by enabling noise reduction and contrast enhancement technique.
Intended for Disease / Condition / Patient Population:
Not applicable as this is a medical image post processing software tool for image enhancement.
Substantial Equivalence:
With regards to safety, the Vitrea Image Denoising software is substantially equivalent to the currently marketed post-processing noise reduction software products that analyze data from medical images. Specifically, intended use, design, function and performance characteristics of Vitrea Image Denoising software are substantially equivalent to the Sapheneia Clarity (K063391) Image Enhancement System, which is manufactured by Sapheneia Commercial Products AB ("predicate device").
The comparison table below shows the equivalence between Vitrea Image Denoising software and the predicate device:
| Vitrea Image Denoising
(Submission Subject) | Sapheneia Clarity (K063391)
(Predicate Device) | Noted Differences |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------|
| Intended Use: | | |
| Vitrea® Image Denoising software is
intended to assist radiologists and
specialists in the enhancement of CT
and 3D-XA image presentation by
enabling noise reduction and contrast
enhancement technique. | The Sapheneia Clarity is intended
for use by radiologists for transfer,
storage, noise reduction, contrast
enhancement and viewing of multi-
modality images from a variety of
diagnostic systems.
The device is also intended to be
used by trained/qualified
technologists for installation and
maintenance of the software. For
your legal protection, it is strongly
recommended that you backup your
original data.
For digital mammography, only
DICOM 'For Presentation' images
should be displayed for primary
image diagnosis. | None |
| Intended Users: | | |
| Radiologists and specialists. | Radiologists and technologists. | None |
2
Image /page/2/Picture/0 description: The image shows the word "VITAL" in bold, sans-serif font. Below the word "VITAL" is the phrase "A Sysmex Medical Systems Group Company" in a smaller font size. The text is black against a white background. The overall impression is a clean and professional logo or heading.
: 上一篇:
:
| Vitrea Image Denoising
(Submission Subject) | Sapheneia Clarity (K063391)
(Predicate Device) | Noted Differences |
|------------------------------------------------|---------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| Modality Support: | | |
| CT and 3D-XA. | Multi-modality (CT, MR, 3D-XA). | Our software supports
CT and 3D-XA datasets
as the predicate device.
Note: Our software
does not support MR
datasets. |
The technological comparison table below shows the equivalence between Vitrea Image Denoising software and the predicate device:
| Vitrea Image Denoising
(Submission Subject) | Sapheneia Clarity (K063391)
(Predicate Device) | Noted Differences |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------|
| Device Description: | | |
| Vitrea Image Denoising software is a
software tool available on the Vitrea
platform. It assists radiologists and
specialists in the enhancement and
viewing of CT and 3D-XA modality
images from a variety of diagnosis
imaging systems by noise reduction
and contrast enhancement. | The Sapheneia Clarity image
processing software reduces noise
and enhances contrast of relevant
structures to increase image quality
through structure adaptation, tissue
adaptation, scale adaptation, and
noise adaptation. | None |
| Random noise does not have a 3D
structure and can thus be separated
from dominant structures. | Using robust estimation methods
the dominant structures are
separated from the embedding
noise. | None |
| Once the structure has been
determined, it is possible to suppress
noise by averaging voxel information
without removing important structural
details for reducing the noise. | Once the structure has been
determined, it is possible to
strengthen the interesting parts
while simultaneously reducing the
noise. | None |
| The acquisition remains the same,
i.e., the image processing can be
generated from CT and 3D-XA
modalities and with predefined or
specific acquisition protocol settings. | The acquisition remains the same,
i.e. the image processing can be
generated from multiple modalities
and with predefined or specific
acquisition protocol settings. | None |
:
3
Image /page/3/Picture/0 description: The image shows the word "VITAL" in bold, black letters. Below the word "VITAL" is the phrase "A Toshiba Medical Systems Group Company" in a smaller font size. The text is all black and the background is white.
100 - 100 - 100 -
:
:
| Vitrea Image Denoising
(Submission Subject) | Sapheneia Clarity (K063391)
(Predicate Device) | Noted Differences |
|-----------------------------------------------------------------|-----------------------------------------------------------------|-------------------|
| Characteristics: | | |
| Image
Enhancement System. | Image
Enhancement System. | None |
| Where Used (Hospital, Home, Ambulance, etc.) | | |
| Medical facility. | Medical facility. | None |
| User Interface: | | |
| The software is designed for use on a
radiology workstation. | The software is designed for use on a
radiology workstation. | None |
| DICOM Standard Compliance: | | |
| The software processes DICOM 3.0
compliant image data. | The software processes DICOM 3.0
compliant image data. | None |
| Noise Reduction Method: | | |
| Image-space noise reduction method. | Image-space noise reduction
method. | None |
| Separation of embedding noise from
dominant structures. | Separation of embedding noise
from dominant structures. | None |
| Level: | | |
| Voxel (volumetric pixel) level noise
reduction. | Pixel level noise reduction. | None |
.
4
Image /page/4/Picture/0 description: The image shows the word "VITAL" in large, bold, black letters. Below the word "VITAL" is the phrase "A Toshiba Medical Systems Group Company" in a smaller font. The text is centered horizontally. The background is white.
Vitrea® Image Denoising Software 510(k) Pre-market Notification
| Vitrea Image Denoising
(Submission Subject) | Sapheneia Clarity (K063391)
(Predicate Device) | Noted Differences |
|------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Vitrea Image Denoising software
employs 3D analysis of the image
structure in the neighborhood of each
voxel. | Sapheneia Clarity employs a
sophisticated statistical analysis of
the image structure in the
neighborhood of each pixel. | Both methods aim at
distinguishing structure
from noise.
Statistical analysis
distinguishes between
the two by studying the
statistical distribution of
the data whereas 3D
analysis studies the first
and second order
derivatives of the image
data to determine the
dominant direction of
structure if it exists. |
Vital Images believes that Vitrea Image Denoising software has the same intended use i.e. enhancement of CT and 3D-XA images, similar indication statement i.e. to be used by trained radiologists and specialists at a medical facility, and similar technological characteristics i.e. image-space noise reduction method as the predicate device.
The above noted difference in the method of image structure analysis, i.e. Vitrea Image Denoising software uses 3D analysis and Sapheneia Clarity uses statistical analysis method to analyze image structure; does not alter the end result of the software, which is to distinguish structure from noise.
Vital Images believes that the verification and validation results demonstrate that Vitrea Image Denoising software is as safe and effective as the predicate device and raises no new issues of safety and effectiveness as compared to the predicate devices. Therefore, Vital Images believes that FDA should find Vitrea Image Denoising software to be substantially equivalent to the predicate device, Sapheneia Clarity.
Summary of Non-Clinical Tests:
The software was designed, developed and tested according to written procedures that included applying risk management. Software testing was completed to ensure the new feature operates according to its requirements and without impact to existing functionality. Testing included verification, validation, and evaluation of previously acquired medical images.
The following quality assurance measures were applied to the development of Vitrea Image Denoising software:
- Risk analysis .
- Requirements reviews .
- Design reviews .
- Verification of the software that included performance and safety testing .
- Validation of the software that included phantom testing and simulated usability testing by . independent experienced medical professionals.
5
Risk analvsis:
Vital Images performed a risk analysis, referring to software hazards associated with the intended use, including severity assessment and mitigation. The analysis was based upon the application of ISO 14971:2012 risk management to medical devices, in compliance with medical device ISO 13485:2012 and IEC 62304:2006 requirements.
All identified risks were reduced as low as possible. The medical benefits of the software outweigh the residual risk for each individual risks together. The overall residual risk for the software was deemed acceptable.
Verification:
The software verification team's primary goal is assuring the software fully satisfies all expected system requirements and features. Test cases were executed against the system features and requirements. As part of creating the test cases, the verification team reviewed and monitored the Requirements Traceability Matrix ("RTM") to ensure coverage of the items within the RTM.
Validation:
The software validation team's primary goal is assuring the software conforms to user needs and intended use. The validation team conducted workflow testing that provided evidence that the system requirements and features were implemented, reviewed and met.
Internal Validation (Phantom Testing):
The software validation team provided internal validation of Vitrea Image Denoising software. Internal validation included internal beta testing and internal user acceptance testing using various Catphan phantoms. The performed phantom tests validated that the amount of noise reduction is clinically significant considering the clinical use of the filter and the resulting spatial resolution, the level of image sharpness or spatial resolution after noise reduction remains acceptable for the diagnostic purposes and the low contrast resolution is not degraded after the noise reduction.
External Validation:
During external validation of Vitrea Image Denoising software, experienced Radiologists and an Interventional Cardiologist evaluated the Vitrea Image Denoising software. Each user felt that the Vitrea Image Denoising software reduces noise and enhances contrast in reconstructed CT and 3D-XA image datasets, while preserving structural details of contrast, spatial size, and 3D structure in the native images for clinically relevant visual assessment.
Summary of Clinical Tests:
The subject of this traditional 510(k) notification. Vitrea Image Denoising software, did not require clinical studies to support safety and effectiveness of the software.
Cyber and Information Security:
-
Confidentiality .
The Vitrea platform relies on built in Windows Login security to limit access to the system. The Vitrea platform can only be installed and configured by an administrator of the Windows machine. -
· Intearity
The Vitrea platform complies with the DICOM standard for transfer and storage of this data and does not modify the contents of DICOM instances. Vitrea platform identifies the data it produces, marking and encoding the appropriate DICOM fields. -
. Availability
The Vitrea platform is always available to the logged on user as long as the Windows machine itself is properly maintained.
6
K140395
Page 7 of 7
Vitrea® Image Deñoising Software 510(k) Pre-market Notification
Image /page/6/Picture/2 description: The image shows the word "VITAL" in bold, black letters. Below the word "VITAL" is the phrase "A Toshiba Medical Systems Group Company" in a smaller font size. The text is centered.
Accountability
The Vitrea platform includes an audit capability that enables accountability by tracking authenticated and authorized user operations along with information accessed. Vitrea audit logs are time stamped, enabling correlation with Windows system logging to track information accessed by a user.
Performance Standard:
The FDA has not established mandatory performance standards and no special controls exist for this device. General software verification and validation tests were conducted to confirm proper function of the device's features.
| Standard No. | Standards
Organization | Standard Title | Version | Date |
|----------------------------------------------------------|---------------------------|-------------------------------------------------------------------------------------------|---------|------------|
| PS 3.1- 3.20
(2011)
(Recognition
Number 12-238) | NEMA | Digital Imaging and
Communications in
Medicine (DICOM) Set
(Radiology) | 3 | 03/16/2012 |
| ISO 14971:2007
(Recognition
Number 5-70) | AAMI / ANSI
/ ISO | Medical Devices -
Applications of Risk
Management to Medical
Devices | 2007 | 03/16/2012 |
| IEC 62304:2006
(Recognition
Number 13-32) | AAMI / ANSI
/ IEC | Medical Device Software -
Software Life Cycle
Processes (Software /
Informatics) | 2006 | 08/20/2012 |
Vitrea Image Denoising software complies with following voluntary recognized consensus standards:
Conclusion:
The testing reported in this 510(k) establishes that Vitrea Image Denoising software is substantially equivalent to the Sapheneia Clarity (K063391) Image Enhancement System and is as safe and effective for its intended use.
7
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/7/Picture/1 description: The image shows a circular seal with text around the perimeter and a symbol in the center. The text reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". The symbol in the center consists of three stylized lines that appear to be flowing or waving.
Public Health Service
Food and Drue Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
May 13, 2014
Vital Images, Inc. % Mr. Parthiv Shah Sr. Regulatory Affairs Specialist 5850 Opus Parkway, Suite 300 MINNETONKA MN 55343
Re: K140395
Trade/Device Name: Vitread Image Denoising Software Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: 11 Product Code: LLZ Dated: February 14, 2014 Received: February 18, 2014
Dear Mr. Shah:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA 's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality svstems (QS) regulation (21 CFR Part 820): and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
8
Page 2-Mr. Shah
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.hum.
Sincerely yours,
. Smh.7)
for
Janine M. Morris Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
9
Indications for Use Form
510(k) Number (if known): _K140395
Device Name: Vitrea® Image Denoising Software
Indications for Use:
Vitrea® Image Denoising software is intended to assist radiologists and specialists in the enhancement of CT and 3D-XA image presentation by enabling noise reduction and contrast enhancement technique.
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Sm.h.7)
Division Sign-Off Office of In Vitro Diagnostics and Radiological Health
K140395 510(k) -
Page 1 of 1